UPSTREAM BIO, INC. (UPB)

Every figure this model derived for UPB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 165,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 261,307,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 279,602,000 AssetsCurrent 2026-06-30
current liabilities 9,988,000 LiabilitiesCurrent 2026-06-30
equity 270,957,000 StockholdersEquity 2026-06-30
ocf -136,344,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,158,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 14,101,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up UPB on one particular measure came for.

RatioValue
current ratio27.99
current ratio reported27.99
revenue growth15.98
revenue growth per share15.98
roic-1391.58
rule of 40-5366.67
sbc pct revenue446.52

What to be careful about

What this model itself distrusts about UPB's figures. Written by the derivation as it ran, not added afterwards.